Outcome of small fibre pathology in fibromyalgia: a real life longitudinal observational study.
Journal
Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
17
03
2022
accepted:
19
05
2022
medline:
30
6
2023
pubmed:
3
8
2022
entrez:
2
8
2022
Statut:
ppublish
Résumé
Small fibre pathology is frequently described in fibromyalgia (FM), but its evolution and its role in clinical outcome of the disease are unclear. This longitudinal observational real-life study aimed to monitor the evolution of skin nerve fibre density in FM, in view of the clinical data. Sixty-two FM patients were controlled by means of skin biopsy and clinical assessment after 18 months of follow-up. At T0 intraepidermal nerve fibre density (IENFD) was normal in 10 patients, reduced at thigh-proximal-site in 46 cases and decreased at proximal and foot-distal-site in 6 patients. At follow up-T1-the IENFD was unchanged, while Brief Pain Inventory-BPI-pain sub score, DN4 and fatigue were improved. Reduced IENFD at proximal and distal sites, together with fatigue and BPI-motor and work sub scores were predictors of more severe disability measured with Fibromyalgia Impact Questionnaire (FIQ) at T1. Reduced IENFD influenced a minor effect of drugs-antiepileptics and/or antidepressants, and physical exercise on fatigue. Small fibre impairment seems stable in medium term in FM. A possible influence of small fibre dysfunction on motor performance could have a role in FM evolution. The beneficial effect of physical exercise could be limited in patients with reduced IENFD.
Identifiants
pubmed: 35916296
pii: 18556
doi: 10.55563/clinexprheumatol/ld0lxn
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM